US Patent Application 18333231. BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA simplified abstract
Contents
BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA
Organization Name
The Regents of the University of California
Inventor(s)
Terry W. Osborn of The Villages FL (US)
Marquis Vawter of Laguna Niguel CA (US)
BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA - A simplified explanation of the abstract
This abstract first appeared for US patent application 18333231 titled 'BIOMARKERS FOR BIPOLAR DISORDER AND SCHIZOPHRENIA
Simplified Explanation
- The patent application describes a new invention related to the diagnosis and differentiation of bipolar disorder and schizophrenia. - The invention involves the use of specific combinations of biomarkers, which are proteins and RNA, to identify and distinguish between these two mental disorders. - The methods described in the patent application can be used to differentiate, diagnose, and treat bipolar disorder and schizophrenia. - The invention relies on examining relevant proteins and RNA in a patient sample to determine the presence of bipolar disorder or schizophrenia. - The use of these biomarkers can provide more accurate and reliable diagnoses, leading to better treatment options for patients.
Original Abstract Submitted
The present invention provides combinations of biomarkers that can be used in the diagnosis and differentiation of bipolar disorder and schizophrenia. The present invention therefore provides methods of differentiating, diagnosing and treating bipolar disorder and schizophrenia, by examining relevant proteins and RNA in a patient sample.
